They’re non-invasive with none of the dreaded prep. But are recently approved home tests for colon cancer as effective as colonoscopies? A North Texas doctor weighs in.
Leap Therapeutics has come crashing down to earth. The biotech axed plans to advance into phase 3 in gastric cancer on the basis of midstage data, sending its stock down 60% to below $1, but it is ...